Amyris, Inc., formerly Amyris Biotechnologies, Inc. develops and provides renewable compounds for a variety of markets. As of September 30, 2010, the Company was building and applying its industrial synthetic biology platform to provide alternatives to petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The Company is focused on a molecule, farnesene, which forms the basis for a range of products varying from specialty chemical applications to transportation fuels, such as diesel. It genetically modifies micro organisms, primarily yeast, and uses them as living factories in established fermentation processes to convert plant-sourced sugars into thousands of molecules. The Company operates research and development laboratories in Emeryville, California, and has built an adjacent pilot facility that tests its yeast strains in 300 liter scale fermentors.